Adial pharmaceuticals announces modifications to phase 3 pivotal trial of ad04 to protect subjects from covid-19

Adial pharmaceuticals inc. - adial pharmaceuticals announces modifications to phase 3 pivotal trial of ad04 to protect subjects from covid-19.adial pharmaceuticals - in process of modifying protocol to reduce no. of in-person visits to clinical sites.adial pharmaceuticals inc - duration of in-person visits is being reduced through removal of non-essential assessments.
ADIL Ratings Summary
ADIL Quant Ranking